Literature DB >> 12069163

In vivo kinetic analysis of covalent binding between N-acetyl-L-cysteine and plasma protein through the formation of mixed disulfide in rats.

Daisuke Harada1, Shinsaku Naito, Isao Hiraoka, Masaki Otagiri.   

Abstract

PURPOSE: This investigation was undertaken to study the relationship between plasma drug clearance and covalent protein-binding kinetics of N-acetyl-L-cysteine (NAC).
METHODS: NAC was intravenously administered to rats via a bolus injection or continuous infusion. Plasma concentrations of protein-unbound and total NAC were analyzed using a compartment model, taking into consideration of the protein binding process, and the apparent first-order binding and dissociation rate constants (kon and koff) were obtained.
RESULTS: Plasma total NAC after a bolus injection showed biphasic elimination with an inflection point at 1 hr. After 1 hr, NAC was largely present in the covalent protein-bound form. During the steady state of the infusion, approximately 30%-40% of plasma NAC bound with protein covalently. The kon, koff, and the elimination rate constant of protein-unbound drug (ke) were 0.23, 0.57, and 4.3 hr(-1). The dissociation half-life of NAC from protein estimated from koff was in agreement with the elimination half-life of plasma total NAC. This suggests that the dissociation of NAC from protein rate-limited the drug elimination in plasma (koff < ke).
CONCLUSION: We demonstrated that plasma total drug clearance is kinetically limited by covalent protein binding. The compartmental model described here is useful for analyzing its kinetics in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069163     DOI: 10.1023/a:1015349928000

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine.

Authors:  B Olsson; M Johansson; J Gabrielsson; P Bolme
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Protective effects of thiol compounds on chromate-induced cytotoxicity in HeLa cells.

Authors:  N Susa; S Ueno; Y Furukawa
Journal:  J Vet Med Sci       Date:  1992-04       Impact factor: 1.267

3.  Determination of reduced, protein-unbound, and total concentrations of N-acetyl-L-cysteine and L-cysteine in rat plasma by postcolumn ligand substitution high-performance liquid chromatography.

Authors:  D Harada; S Naito; Y Kawauchi; K Ishikawa; O Koshitani; I Hiraoka; M Otagiri
Journal:  Anal Biochem       Date:  2001-03       Impact factor: 3.365

4.  Covalent binding between bucillamine derivatives and human serum albumin.

Authors:  R Narazaki; M Hamada; K Harada; M Otagiri
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

5.  A pharmacokinetic analysis program (multi) for microcomputer.

Authors:  K Yamaoka; Y Tanigawara; T Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1981-11

6.  Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.

Authors:  C I Johnston; J A Millar; B P McGrath; P G Matthews
Journal:  Lancet       Date:  1979-09-08       Impact factor: 79.321

7.  Ebselen-binding equilibria between plasma and target proteins.

Authors:  V Ullrich; P Weber; F Meisch; F von Appen
Journal:  Biochem Pharmacol       Date:  1996-07-12       Impact factor: 5.858

8.  New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11.

Authors:  C A Fink; Y Qiao; C J Berry; Y Sakane; R D Ghai; A J Trapani
Journal:  J Med Chem       Date:  1995-12-22       Impact factor: 7.446

9.  Effects of N-acetylcysteine stereoisomers on oxygen-induced lung injury in rats.

Authors:  B Särnstrand; A Tunek; K Sjödin; A Hallberg
Journal:  Chem Biol Interact       Date:  1995-02       Impact factor: 5.192

10.  Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases.

Authors:  G Boman; U Bäcker; S Larsson; B Melander; L Wåhlander
Journal:  Eur J Respir Dis       Date:  1983-08
View more
  5 in total

1.  Kinetic analysis of covalent binding between N-acetyl-L-cysteine and albumin through the formation of mixed disulfides in human and rat serum in vitro.

Authors:  Daisuke Harada; Shinsuku Naito; Masaki Otagiri
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

2.  T₃-induced liver AMP-activated protein kinase signaling: redox dependency and upregulation of downstream targets.

Authors:  Luis A Videla; Virginia Fernández; Pamela Cornejo; Romina Vargas; Paula Morales; Juan Ceballo; Alvaro Fischer; Nicolás Escudero; Oscar Escobar
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

3.  Systemic dendrimer-drug nanomedicines for long-term treatment of mild-moderate cerebral palsy in a rabbit model.

Authors:  Zhi Zhang; Yi-An Lin; Soo-Young Kim; Lilly Su; Jinhuan Liu; Rangaramanujam M Kannan; Sujatha Kannan
Journal:  J Neuroinflammation       Date:  2020-10-25       Impact factor: 9.587

Review 4.  N-acetylcysteine (NAC) and Its Role in Clinical Practice Management of Cystic Fibrosis (CF): A Review.

Authors:  Marta Guerini; Giorgia Condrò; Valeria Friuli; Lauretta Maggi; Paola Perugini
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-11

5.  Reestablishment of ischemia-reperfusion liver injury by N-acetylcysteine administration prior to a preconditioning iron protocol.

Authors:  Virginia Fernández; Romina Vargas; Valentina Castillo; Nicolás Cádiz; Daniela Bastías; Sebastián Román; Gladys Tapia; Luis A Videla
Journal:  ScientificWorldJournal       Date:  2013-10-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.